Cogent Biosciences, Inc.
NASDAQ:COGT
10.21 (USD) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | 2017 Q2 | 2017 Q1 | 2016 Q3 | 2015 Q3 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 5.588 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.312 | 0.528 | 7.031 | 15.288 | 1.02 | 3.138 | 3.053 | 3.805 | 2.043 | 1.666 | 2.22 | 2.123 | 2.331 | 2.079 | 1.827 | 52.176 | 1.002 |
| Cost of Revenue
| 1.08 | 1.066 | 0.794 | 0.855 | 1.216 | 0.723 | 0.937 | 3.711 | 0.097 | 0.069 | 0.068 | 0.048 | 0.014 | 0.017 | 6.108 | 5.003 | 5.129 | 9.498 | 10.354 | 10.335 | 10.617 | 11.51 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 39.658 | 0.766 |
| Gross Profit
| -1.08 | -1.066 | 4.794 | -0.855 | -1.216 | -0.723 | -0.937 | -3.711 | -0.097 | -0.069 | -0.068 | -0.048 | -0.014 | -0.017 | -6.108 | -4.691 | -4.601 | -2.467 | 4.934 | -9.315 | -7.479 | -8.457 | 3.805 | 2.043 | 1.666 | 2.22 | 2.123 | 2.331 | 2.079 | 1.827 | 12.518 | 0.236 |
| Gross Profit Ratio
| 0 | 0 | 0.858 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -776,013,213,059.602 | -15.035 | -8.714 | -0.351 | 0.323 | -9.132 | -2.383 | -2.77 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0.24 | 0.236 |
| Reseach & Development Expenses
| 53.214 | 52.705 | 48.719 | 50.127 | 38.871 | 36.038 | 36.742 | 29.936 | 29.479 | 25.47 | 20.514 | 14.798 | 12.388 | 8.213 | 6.107 | 51.913 | 5.129 | 9.498 | 10.354 | 10.335 | 10.617 | 12.403 | 10.765 | 10.252 | 9.126 | 8.142 | 7.562 | 8.177 | 7.141 | 6.952 | 0 | 0 |
| General & Administrative Expenses
| 10.093 | 9.699 | 9.509 | 9.453 | 8.214 | 7.199 | 7.003 | 6.885 | 6.376 | 5.948 | 5.126 | 5.021 | 4.904 | 4.587 | 5.348 | 5.598 | 2.802 | 3.674 | 2.694 | 2.721 | 3.062 | 2.491 | 2.044 | 2.367 | 1.979 | 1.064 | 1.441 | 1.324 | 0.971 | 0.944 | 17.669 | 4.178 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.699 | 0.524 |
| SG&A
| 10.093 | 9.699 | 9.509 | 9.453 | 8.214 | 7.199 | 7.003 | 6.885 | 6.376 | 5.948 | 5.126 | 5.021 | 4.904 | 4.587 | 5.348 | 5.598 | 2.802 | 3.674 | 2.694 | 2.721 | 3.062 | 2.491 | 2.044 | 2.367 | 1.979 | 1.064 | 1.441 | 1.324 | 0.971 | 0.944 | 21.368 | 4.702 |
| Other Expenses
| 0.044 | -0.001 | -0.007 | 0 | 0.268 | 2.382 | 2.017 | 0.259 | 0.656 | 0.677 | 0.621 | 0.62 | 0.623 | 0.947 | 0.015 | -0.27 | 0.007 | 0 | -0.004 | 0.082 | 0 | 0 | -0.01 | 0.003 | 0.157 | 0.17 | 0.091 | 0.07 | 0.073 | 0.04 | 0 | 0 |
| Operating Expenses
| 63.307 | 62.404 | 58.228 | 59.58 | 47.085 | 43.237 | 43.745 | 36.821 | 35.855 | 31.418 | 25.64 | 19.819 | 17.292 | 12.8 | 11.455 | 57.511 | 7.931 | 13.172 | 13.048 | 13.056 | 13.679 | 14.894 | 12.809 | 12.619 | 11.105 | 9.206 | 9.003 | 9.501 | 8.112 | 7.896 | 24.875 | 4.759 |
| Operating Income
| -64.387 | -62.404 | -58.228 | -59.58 | -47.085 | -43.237 | -43.745 | -36.821 | -35.855 | -31.418 | -25.64 | -19.819 | -17.292 | -12.8 | -11.455 | -57.199 | -7.403 | -6.141 | 2.24 | -12.036 | -10.541 | -11.841 | -9.004 | -10.576 | -9.439 | -6.986 | -6.88 | -7.17 | -6.033 | -6.069 | -12.357 | -4.523 |
| Operating Income Ratio
| 0 | 0 | -10.42 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1,455,342,396,137.721 | -183.33 | -14.021 | -0.873 | 0.147 | -11.8 | -3.359 | -3.878 | -2.366 | -5.177 | -5.666 | -3.147 | -3.241 | -3.076 | -2.902 | -3.322 | -0.237 | -4.514 |
| Total Other Income Expenses Net
| 5.437 | -0.001 | -0.007 | 4.198 | 0.268 | 4.65 | 4.127 | 1.759 | 0.656 | 0.784 | 0.621 | 0.62 | 0.623 | 0.947 | 0.046 | 7.193 | 0.007 | 0.047 | -0.004 | 0.082 | 0.025 | 0.15 | -0.01 | 0.003 | 0.157 | 0.17 | 0.091 | 0.07 | 0.073 | 0.04 | -1.88 | -0.003 |
| Income Before Tax
| -58.95 | -58.348 | -54.365 | -55.382 | -44.076 | -38.587 | -39.618 | -35.062 | -34.927 | -30.634 | -24.912 | -19.084 | -16.549 | -11.728 | -11.339 | -49.983 | -7.393 | -6.094 | 2.297 | -11.923 | -10.516 | -11.691 | -8.606 | -10.168 | -9.023 | -6.735 | -6.69 | -7 | -5.863 | -5.939 | -14.237 | -4.526 |
| Income Before Tax Ratio
| 0 | 0 | -9.729 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1,440,604,751,619.87 | -160.202 | -14.002 | -0.867 | 0.15 | -11.689 | -3.351 | -3.829 | -2.262 | -4.977 | -5.416 | -3.034 | -3.151 | -3.003 | -2.82 | -3.251 | -0.273 | -4.517 |
| Income Tax Expense
| 0 | -4.057 | -3.87 | -0.855 | -3.957 | -4.65 | -4.127 | -1.759 | -1.433 | -0.784 | -0.728 | -0.115 | -0.12 | -0.125 | -0.118 | -7.608 | -0.003 | 0 | -0.375 | -0.349 | 0 | 0 | -0.408 | -0.405 | -0.259 | -0.081 | -0.099 | -0.1 | -0.097 | -0.09 | 4.493 | 0.124 |
| Net Income
| -58.95 | -58.348 | -54.365 | -55.382 | -44.076 | -33.937 | -35.491 | -33.303 | -34.927 | -29.85 | -24.912 | -19.084 | -16.549 | -11.728 | -11.339 | -49.983 | -7.393 | -6.094 | 2.297 | -11.923 | -10.516 | -11.691 | -8.606 | -10.168 | -9.023 | -6.735 | -6.69 | -7 | -5.863 | -5.939 | -9.744 | -4.402 |
| Net Income Ratio
| 0 | 0 | -9.729 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1,440,604,751,619.87 | -160.202 | -14.002 | -0.867 | 0.15 | -11.689 | -3.351 | -3.829 | -2.262 | -4.977 | -5.416 | -3.034 | -3.151 | -3.003 | -2.82 | -3.251 | -0.187 | -4.393 |
| EPS
| -0.59 | -0.62 | -0.63 | -0.64 | -0.59 | -0.48 | -0.5 | -0.48 | -0.71 | -0.66 | -0.57 | -0.48 | -0.43 | -0.34 | -0.59 | -5.07 | -0.95 | -0.81 | 0.28 | -1.56 | -1.38 | -1.55 | -1.15 | -1.36 | -1.24 | -2.64 | -1.14 | -1.2 | -1 | -1.01 | -0.77 | -1.17 |
| EPS Diluted
| -0.59 | -0.62 | -0.63 | -0.64 | -0.59 | -0.48 | -0.5 | -0.48 | -0.71 | -0.66 | -0.57 | -0.48 | -0.43 | -0.34 | -0.59 | -5.07 | -0.95 | -0.81 | 0.28 | -1.56 | -1.38 | -1.55 | -1.15 | -1.36 | -1.24 | -2.64 | -1.14 | -0.95 | -0.79 | -0.8 | -0.77 | -1.17 |
| EBITDA
| -63.307 | -61.338 | -57.434 | -59.58 | -47.085 | -42.514 | -43.745 | -33.11 | -35.855 | -31.349 | -25.572 | -19.771 | -17.278 | -12.783 | -11.486 | -64.662 | -7.117 | -5.846 | 2.24 | -12.036 | -10.21 | -11.511 | -8.652 | -10.246 | -9.114 | -6.672 | -6.573 | -6.87 | -5.747 | -5.791 | -9.32 | -4.466 |
| EBITDA Ratio
| 0 | 0 | -10.278 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1,459,280,904,586.456 | -207.25 | -13.479 | -0.831 | 0.147 | -11.8 | -3.254 | -3.77 | -2.274 | -5.015 | -5.471 | -3.005 | -3.096 | -2.947 | -2.764 | -3.17 | -0.179 | -4.457 |